Skip to main navigation Skip to search Skip to main content

Clinical implications of E-cadherin associated hereditary diffuse gastric cancer

  • R. C. Fitzgerald*
  • , C. Caldas
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

96 Scopus citations

Abstract

Approximately 1-3% of gastric cancers arise as a result of inherited gastric cancer predisposition syndromes. These may be of the diffuse or intestinal type. Linkage analysis has recently implicated E-cadherin mutations in an estimated 25% of families with an autosomal dominant predisposition to diffuse type gastric cancers. This subset of gastric cancer has been termed hereditary diffuse gastric cancer (HDGC).

Original languageEnglish
Pages (from-to)775-778
Number of pages4
JournalGut
Volume53
Issue number6
DOIs
StatePublished - Jun 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Clinical implications of E-cadherin associated hereditary diffuse gastric cancer'. Together they form a unique fingerprint.

Cite this